Skip to content
10-K

Annual Report

AMPIO PHARMACEUTICALS, INC.

0001558370-24-004090

← back to feed
Filed
Mar 27, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 15, 2024 1.14M sh
Shares Diluted FY 2023 · Dec 31, 2023 810.11K sh
Shares Diluted restated FY 2023 · Dec 31, 2022 753.62K sh
Operating Cash Flow FY 2023 · Dec 31, 2023 −$8.56M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$21.13M
Cash And Equivalents FY 2023 · Dec 31, 2023 $4.09M
Cash And Equivalents FY 2023 · Dec 31, 2022 $12.65M
Stockholders Equity FY 2023 · Dec 31, 2023 $3.36M
Stockholders Equity FY 2023 · Dec 31, 2022 $11.79M
Stockholders Equity FY 2023 · Dec 31, 2021 $27.28M
Current Liabilities FY 2023 · Dec 31, 2023 $2.38M
Current Liabilities FY 2023 · Dec 31, 2022 $1.19M
Total Liabilities FY 2023 · Dec 31, 2023 $2.38M
Total Liabilities FY 2023 · Dec 31, 2022 $1.8M
Current Assets FY 2023 · Dec 31, 2023 $5.74M
Current Assets FY 2023 · Dec 31, 2022 $13.33M
Total Assets FY 2023 · Dec 31, 2023 $5.74M
Total Assets FY 2023 · Dec 31, 2022 $13.59M
Eps Diluted FY 2023 · Dec 31, 2023 −$10.66
Eps Diluted restated FY 2023 · Dec 31, 2022 −$29.32
Eps Basic FY 2023 · Dec 31, 2023 −$10.66
Eps Basic restated FY 2023 · Dec 31, 2022 −$21.68
Rd Expense FY 2023 · Dec 31, 2023 $2.44M
Rd Expense FY 2023 · Dec 31, 2022 $8.92M
Net Income FY 2023 · Dec 31, 2023 −$8.63M
Net Income FY 2023 · Dec 31, 2022 −$16.34M